Books
in black and white
Main menu
Share a book About us Home
Books
Biology Business Chemistry Computers Culture Economics Fiction Games Guide History Management Mathematical Medicine Mental Fitnes Physics Psychology Scince Sport Technics
Ads

Principles and practice of Clinical parasitology - Gillespie S.

Gillespie S. Principles and practice of Clinical parasitology - Wiley publishing , 2001. - 675 p.
ISBN 0-471-97729-2
Download (direct link): principlesandpracticeofclin2001.pdf
Previous << 1 .. 2 3 < 4 > 5 8 9 10 .. 212 >> Next

X
PREFACE
amoebas and these may lead to the identification of new virulence determinants, or targets for chemotherapy or vaccine development. Although new treatments and vaccines have progressed more slowly than in other infection disciplines, effective chemotherapy is now available for almost all parasitic infections.
An international panel of authors have drawn together their experience and understanding of parasitic infections. The chapters contain a clinically orientated overview of all the major
parasitic infections in medical practice. The editors hope that those who read and use this book will develop their clinical diagnostic and therapeutic skills, and that these skills will be used for the benefit of those who most need them—the people who are often the poorest in the world community.
Stephen H. Gillespie Richard D. Pearson
Principles and Practice of Clinical Parasitology. Edited by S. Gillespie & Richard D. Pearson Copyright © 2001 John Wiley & Sons Ltd Print ISBN 0-471-97729-2 Online ISBN 0-470-84250-4
Index
Numbers in italics indicate figures; those in bold indicate tables. Plates are denoted by ‘p’.
abdominal angiostrongyliasis 545 Acanthamoeba keratitis 281 clinical management 282 diagnosis 281 prevention 282 Acanthamoeba spp. culture 273-4 epidemiology 276-7 history 269 immunology 275-6 life cycle 271, 272, 273 molecular biology 276 taxonomy 270-1
see also granulomatous amebic encephalitis acanthopodia 272, 273 acetylcholinesterases 570 acid-fast stains 152, 157, 168, 187 acidosis 62, 78
acquired immunity and helminth vaccination 28
acridine orange 73, 254
actin
rearrangement on invasion by Cryptosporidium parvum 143-4 in Toxoplasma gondii motility 119 acute dermatolymphangioadenitis (ADLA) 443 acute necrotizing colitis 207 adenolymphangitis (ADL) 436, 437 adenopathy 440
adhesins, Trichomonas vaginalis 247, 249 adventitial layer, Echinococcus granulosus 593, 594, 598 aflatoxins 413
African Programme for Onchocerciasis Control (APOC) 474 African trypanosomiasis clinical features 327 clinical management 329 hemolymphatic stage 329-30 meningoencephalitic stage 330 history 17-18, 315, 335 immunology 320-1
immunopathology 321-2 laboratory diagnosis antibody tests 329 antigen tests 329 parasite detection 327-8 organism see Trypanosoma brucei prevention and control
disease suppression 331-2 vaccination 332 vector control 331 WHO recommendations 315 agar plate culture of Strongyloides stercoralis 490 age
at first infection related to R0 26 optimum for helminth vaccination, mathematical models 27-8, 29 age prevalences
cryptosporidiosis 148 Entamoeba infections 202, 204 intestinal nematode infections 565 malaria 68
schistosomiasis 377, 379 strongyloidiasis 488-9 toxocariasis 508 Trichomonas tenax infections 257 age-structured dynamic cost-benefit analysis model 34-5
AIDS/HIV infection cryptosporidiosis in 140, 147, 148, 150, 153-4 cyclosporiasis treatment 168 giardiasis in 225
granulomatous amebic encephalitis in 278, 279 isosporiasis in 156, 157, 158 microsporidioses in 181, 185, 186, 190, 191 toxoplasmosis in 114, 125-6, 132-3 trichomoniasis and transmission risk of 248 Trypanosoma cruzi brain abscesses in 344 visceral leishmaniasis in 293, 294, 303, 307 airport malaria 68 Alaria americana 536, 549, 637, 645
648
INDEX
albendazole treatment
cutaneous larva migrans 539 cystic echinococcosis 604-5 cysticercosis 627
deworming randomized trial 36, 37 giardiasis 231, 232 intestinal nematode infection 578 loiasis 448
lymphatic filariasis 443 microsporidiosis 190
multivesicular/alveolar echinococcosis 605-6 strongyloidiasis 492 taeniasis 626 toxocariasis 515 trichinellosis 530, 531 alveolar hydatid growth 594 amastigotes
Leishmania spp. 288, 290, 291, 294 detection 304 pathogenesis 291, 292 Trypanosoma cruzi 336, 337, 338 amebapores 201 amebas
taxonomy 270-1 see also specific species amebic dysentery/colitis 206-7, 210, 211 amebic liver abscesses 205, 207-8 diagnosis 208, 209, 210, 211 management 211 amebic meningoencephalitis see primary amebic meningoencephalitis ameboid form, Blastocystis hominis 359 American trypanosomiasis see Chagas’ disease aminosidine see paromomycin amocarzine 472
amphotericin B 281, 306, 307, 308 Ancyclostoma caninum/A. braziliense 535-7 epidemiology 538 life-cycle 537-8 pathogenesis 538, 570
see also cutaneous larva migrans; eosinophilic enteritis Ancyclostoma duodenale 569, 570, 571 Andre, Nicholas 2 anemia
in babesiosis 103 in hookworm infection 571 in malaria 62, 79 in schistosomiasis 384, 390 angiostrongyliasis
Angiostrongylus/angiostrongyliasis 536, 543 A. cantonensis 543 A. costaricensis 543 clinical features 545 epidemiology 543, 544 laboratory diagnosis 545 life-cycle 544
pathogenesis 544-5 treatment 545-6 anion-exchange centrifugation technique 328 Annesley, James 12
annual transmission potential (ATP) 464 Anopheles mosquitoes 55 control 87
house screening against 88 insecticide resistance 87 microsporidia in 187 in Plasmodium life-cycle 56 prevention of bites 88 variation and malaria transmission 67 anticoagulants, hookworm 538, 570 antigen detection tests Angiostrongylus spp. 545 Echinococcus spp. 603, 604 Entamoeba histolytica 209-10 Giardia lamblia 229 Schistosoma spp. 394 Strongyloides stercoralis 492 Taenia spp. 625 Toxocara spp. 514 Trichomonas vaginalis 254 Trypanosoma brucei 329 Wuchereria bancrofti 441 antigenic variation, mechanisms in Trypanosoma brucei 323, 324-5 antimalarial antibodies 64 antimalarial drug resistance 69, 78 chloroquine 54, 75, 76-7, p.vi countries affected 89, p.vi mis-diagnosed babesiosis 106 pyrimethamine-sulfadioxine 84 quinine 77 tests for 69, 74 antimalarial drugs 81-6 see also specific drugs antimony dimercaptosuccinate 371 ants 421 apicoplasts 114
Previous << 1 .. 2 3 < 4 > 5 8 9 10 .. 212 >> Next